CONGRESS FOR VOTERS

Debbie Dingell (D-MI)

Access to Breast Cancer Diagnosis Act of 2025

H.R. 3037 · House bill Health

A Democratic bill with 16 Republican cosponsors · See all 67 cosponsors

Last activity — Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

In committee

Introduced and handed to a committee in the chamber it started in.

The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.

Its path through Congress

  1. Introduced
  2. In Committee

What this bill would do

This bill is called the Access to Breast Cancer Diagnosis Act of 2025. It stops group health plans and health insurance issuers from putting cost-sharing requirements on diagnostic and supplemental breast examinations. Cost-sharing requirements include things like deductibles, coinsurance, and copayments. The bill allows plans to still require timely prior authorization or use other appropriate utilization controls for these examinations. It also applies these rules to grandfathered health plans and high-deductible health plans that work with health savings accounts. These changes apply to plan years starting on or after January 1, 2026.

Yes· 3 of 7

  • Scored +9

    Would women be better off under this?

    This bill directly targets health expenses specific to women's breast health, providing significant financial and access benefits.

  • Scored +8

    Does this make health care easier to get in general?

    By removing financial barriers like deductibles and copayments for diagnostic and supplemental breast exams, the bill significantly improves access to critical cancer care.

  • Scored +7

    Does this give people more protection from unfair business practices?

    By prohibiting cost-sharing for essential breast cancer diagnostic and supplemental examinations, the bill increases consumer protections for health plan members.

The opposite

No question was scored the opposite.